Latest in Cardiology from ACC.org

• API-CAT Analysis: Recurrent VTE Uncommon, Associated With Poor Short-Term Survival
  Recurrent venous thromboembolism (VTE) is uncommon but associated with poor short-term survival among patients with cancer-associated thrombosis on extended apixaban therapy after at least six months of anticoagulation treatment, according to a post-hoc analysis of the API-CAT trial published July 13 in Circulation.
• Protein Intake and Cardiovascular Health: Separating Signal From Noise
  Media attention to protein has increased and resulted in significant scrutiny. Many individuals are unsure of how much protein to consume and whether higher intakes, like those recommended for exercise, are safe for cardiovascular health.
• ACC CardiaCast: The What, Who, When and Why of Screening of UACR
  In this first episode of The Increasing Role of Urine Albumin-Creatinine Ratio (UACR) in Cardiovascular Care series, Dr. Ankeet Bhatt interviews Dr. Katherine Tuttle on UACR, its role in kidney disease, and the importance of screening.
• Older Adults With Obesity See Gains in BP, Lipid Control, But Not Young Adults
  Across seven industrialized countries, differences in systolic blood pressure (SBP) and non–HDL-C between adults with obesity and normal body mass index (BMI) have narrowed substantially over time, particularly among adults over 40 years old. However, young adults with obesity remain at higher cardiometabolic risk, according to new research from the NCD Risk Factor Collaboration published […]
• SUMMIT: Benefits From Tirzepatide Similar By Sex in Patients With Obesity-Related HFpEF
  Treatment benefit from tirzepatide was consistent across multiple domains of heart failure (HF) severity and did not differ by sex, despite women exhibiting greater adiposity, symptom severity and poorer exercise capacity but lower left ventricular mass and paracardiac fat deposition when compared to men, according to a secondary analysis of the SUMMIT trial published July […]